ID   cST2146
AC   CVCL_IQ94
SY   ST2146
DR   ABCD; ABCD_AC985
DR   Wikidata; Q54814685
RX   Patent=US8048417;
RX   PubMed=12671694;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 02003.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P24821; Human TNC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 5
//
RX   Patent=US8048417;
RA   De Santis R., Anastasi A.M.;
RT   "Anti-human tenascin monoclonal antibody.";
RL   Patent number US8048417, 01-Nov-2011.
//
RX   PubMed=12671694; DOI=10.1038/sj.bjc.6600818;
RA   De Santis R., Anastasi A.M., D'Alessio V., Pelliccia A., Albertoni C.,
RA   Rosi A., Leoni B., Lindstedt R., Petronzelli F., Dani M.,
RA   Verdoliva A., Ippolito A., Campanile N., Manfredi V., Esposito A.,
RA   Cassani G., Chinol M., Paganelli G., Carminati P.;
RT   "Novel antitenascin antibody with increased tumour localisation for
RT   Pretargeted Antibody-Guided RadioImmunoTherapy (PAGRIT).";
RL   Br. J. Cancer 88:996-1003(2003).
//